Biochemistry, Genetics and Molecular Biology
Nested Gene
64%
Sample
33%
Association
32%
Transactivation
32%
DNA-binding Protein
32%
Nuclear Import
32%
Next Generation Sequencing
32%
Genetic Architecture
32%
Age
32%
Kinesin
32%
Genetic Screening
32%
Transactive Response Dna Binding Protein-43
32%
Mutation
25%
Genetics
23%
Survival
17%
Chromosome 21
16%
Single Nucleotide Polymorphism
16%
Heritability
16%
Ferritin
13%
Creatine Kinase
13%
Tumor Necrosis Factors
13%
Interferon
9%
Interleukin 6
9%
Neurofilament
9%
Light Chain
9%
Interleukin 5
9%
Interleukin 2
9%
Clinical Trial Design
9%
DNA
8%
C-Terminus
8%
Genome-Wide Association Study
8%
Spectrum
8%
N-Terminus
8%
Phenotype
8%
Contrast
8%
Loss of Function Mutation
8%
Senescence
7%
Protein
6%
Electric Potential
5%
Time
5%
Screening
5%
Medicine and Dentistry
Amyotrophic Lateral Sclerosis
72%
Frontotemporal Lobar Degeneration
64%
Protein
41%
Sense
32%
Complementary RNA
32%
Diagnosis
32%
Serositis
32%
RNA
32%
Nuclear Import
32%
DNA Binding Protein
32%
Transactivation
32%
Patient
27%
Neuron
18%
Disease
15%
Ferritin
13%
Creatine Kinase
13%
Frontal Lobe
13%
Tumor Necrosis Factor
13%
Survival
9%
Disease Exacerbation
9%
Interleukin 6
9%
Biological Marker
9%
Antisense
9%
Interleukin 5
9%
Light Chain
9%
Neurofilament
9%
Gene
9%
Interferon
9%
Plasma
9%
Cytokine
9%
Interleukin 2
9%
Pathogenesis
5%
Analysis
5%
Disease
5%
Screening
5%
Diagnostics
5%
Health Care Cost
5%
Gene Linkage
5%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
Gene
48%
Kinesin
32%
Neuromuscular
32%
Nuclear Import
32%
Transactivation
32%
Protein
32%
Frontotemporal Dementia
32%
DNA-binding Protein
32%
Predictor
18%
Creatine Kinase
13%
Tumor Necrosis Factor Alpha
13%
Ferritin
13%
Light Chain
9%
Interleukin 5
9%
Neurofilament
9%
Interleukin 6
9%
Interferon
9%
Interleukin 2
9%
DNA
8%
C-Terminus
8%
Neurodegenerative Disorder
8%
Amino Terminal Sequence
8%
Loss of Function Mutation
8%
Phenotype
8%
Hereditary Spastic Paraplegia
8%
Genome-Wide Association Study
8%
Cytoskeletal Defects
8%
Polymorphism
5%
